An expanded access record providing NanoDoce (sterile nanoparticulate docetaxel) Powder for Suspension in Urogenital Neoplasms, sponsored by NanOlogy, LLC. No longer available. Per ClinicalTrials.gov, last updated 2026-01-23.
Sponsored by NanOlogy, LLC · Expanded access
NanOlogy may consider offering expanded access to NanoDoce for patients who do not meet the enrollment criteria of clinical trials in progress.
135 studies on the registry are indexed under Urogenital Neoplasms; 47 are open to participants now.
Browse Urogenital Neoplasms studies →NanOlogy, LLC is the lead sponsor of 12 studies on the registry; 1 is open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 8 (100%) have results posted.
Counted across the registry records on this site, refreshed daily.
-
Exclusion Criteria:
-
Also known as: docetaxel
No study locations are listed for this record.
Expanded access is arranged between your doctor and the company. Ask your care team to contact the provider listed on this record.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
NanOlogy, LLC